AskNiveshClosed·18:45 IST
  • Stocks
  • ·
  • Funds
  • ·
  • Signals

AskNivesh is a research desk for Indian markets, US equities, fund data, and disclosure trails. Built for investors who want source-backed context without the noise.

Market

  • Overview
  • Stocks
  • Indexes
  • Sectors
  • ETFs
  • Funds
  • IPOs
  • Earnings

US Market

  • Political Trades
  • Disclosure Leaderboard
  • Politicians
  • Consensus Trades
  • Late Disclosures
  • Sector Tilt
  • US Stocks

Market Pulse

  • Market Pulse
  • Global Markets
  • Currency Rates
  • Signals
  • FII DII Activity
  • Corporate Actions
  • RBI Macro
  • Derivatives
  • Currency Derivatives
  • Index Derivatives
  • Commodity Derivatives
  • F&O Expiries

Data

  • Glossary
  • Methodology
  • Analysis Methods
  • Technical Analysis
  • Candle Patterns
  • Brokers
  • Depositories
  • SEBI Intermediaries
  • Exchange Holidays
  • Global Investing
  • Sitemap

Company

  • About Us
  • Contact

Legal

  • Terms and Conditions
  • Privacy Policy
  • Disclaimer
  • Methodology
  • ·Glossary
  • ·Sitemap
  • ·Contact
Browse stocks by letter
AllABCDEFGHIJKLMNOPQRSTUVWXYZOthers

Research and education only. Not investment advice under SEBI (IA) Regulations 2013, not a research report under SEBI (RA) Regulations 2014. Not a SEBI-registered Adviser, Analyst, or distributor.

AskNivesh©2026
asknivesh.com
← Back to APOLLOHOSP

Apollo Hospitals Enterprise Limited: Detailed financials

Line items extracted directly from the company's NSE-filed XBRL. Click + to expand subtotals. Click any row to chart it. All values in ₹ crore.

ParticularsJun-24Sep-24Dec-24Mar-25Jun-25Sep-25Dec-25Mar-26
Revenue
5,0865,5895,5275,5925,8426,3046,4776,606
Other income
3738646140555344
Segment revenue (incl. inter-segment)
5,0865,5895,5275,5925,8426,3046,4776,606
Expenses
4,7045,0765,0605,1485,3135,6905,8445,938
Cost of materials consumed
690744626694740779745777
Purchases of stock-in-trade
1,9112,1102,2922,2442,3162,4652,6632,613
Change in inventories
223-17-9-80.20-2512
Employee benefit expense
658700686725713767749772
Finance costs
116118110115108110113119
Depreciation & amortisation
177184185211215218219224
Other expenses
1,1291,2161,1781,1691,2301,3521,3811,420
EBITDA
7118548268318929969991,054
EBIT
534670641620677778780830
Operating profit
498631577559637723746786
Exceptional items
-------19-
Profit Before Tax
418552531505569668667711
Tax expense
114162157101142181166170
Deferred tax
2222-18171919-26
Net Profit
316396379414441494516551
Financial Ratios
Operating Profit Margin
9.79%11.29%10.44%10.00%10.90%11.47%11.52%11.90%
EBITDA Margin
13.98%15.28%14.94%14.86%15.27%15.80%15.42%15.96%
Net Profit Margin
6.21%7.09%6.86%7.40%7.55%7.84%7.97%8.34%
Earnings Per Share (₹)
21.2326.3425.8927.1030.1033.1934.9436.82

Revenue

₹ in crore

Click any row in the table to chart it here.

Source: NSE integrated filing results & XBRL. Figures are exact values reported by the issuer at filing time, never estimated. Ratios (operating margin, net margin) and EBITDA / EBIT / FCF / shareholders' funds are computed from the filed line items.